Pancreatic Cancer Research

ResearcherPost Graduate Institute of Medical Education and ResearchNo recent work listed

Ritambhra Nada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8955-1428; OpenAlex author ID A5084921714. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. CCR4+ monocytic myeloid-derived suppressor cells are associated with the increased epithelial-mesenchymal transition in pancreatic adenocarcinoma patients. Co-author DOI 10.1016/j.imbio.2022.152210↗
  2. IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients. Co-author DOI 10.1111/sji.13107↗
  3. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the… Last author DOI 10.1007/s12149-017-1193-0↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anjali Aggarwal · 2 shared papers, 2021–2022 · strength 0.32
  2. Daisy Sahni · 2 shared papers, 2021–2022 · strength 0.32
  3. Vinit Sharma · 2 shared papers, 2021–2022 · strength 0.32
  4. Surinder Singh Rana · 1 shared paper, 2017 · strength 0.08
  5. Rajesh Gupta · 1 shared paper, 2017 · strength 0.08
  6. Sampath Santhosh · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.